Vnitr Lek 2015, 61(1):15-23

Utility of Pneumonia Severity Index in hospitalized patients with pneumonia in intensive respiratory care units

Beáta Hutyrová1, Petr Jakubec1,*, Zdena Šindelářová1, Jana Šubová1, Kateřina Langová2, Vítězslav Kolek1
1 Klinika plicních nemocí a tuberkulózy LF UP a FN Olomouc, přednosta prof. MUDr. Vítězslav Kolek, DrSc.
2 Ústav lékařské biofyziky LF UP Olomouc, přednostka prof. RNDr. Hana Kolářová, CSc.

Introduction:
The aim of this study was to evaluate the prognostic value of Pneumonia Severity Index (PSI) for prediction of 30-day mortality in patients admitted to intensive care unit (ICU) for community-acquired pneumonia (CAP). In patients with CAP, comorbidities, complications, and physical, laboratory, radiological and microbiological findings were evaluated relative to their prognosis.


Patient and methods:
In the study, 197 patients with CAP, hospitalised at ICU of Department of Respiratory Medicine, University Hospital Olomouc between 2008 and 2012, were enrolled. Risk factors according to PSI were assessed in all patients.

Results:
In the studied cohort of patients with CAP, mean values of PSI were 115.4 ± SD 30.4 points. Overall, 29 patients (14.7 %) deceased. When comparing deceased and survived patients, statistically significant differences were found in PSI (mean ± SD: 137.4 ± 26.1 vs 111.7 ± 29.6 points, p < 0.0001), age (mean ± SD: 76.3 ± 12.9 vs 65.5 ± 14.7 years, p < 0.0001), incidence of heart diseases (86.2 % vs 67.3 %, p = 0.04) and ischaemic heart disease (58.6 % vs 38.7 %, p = 0.04). Assessment of physical and laboratory findings showed that deceased patients had significantly increased incidence of tachycardia above 90/min (51.7 % vs 27.4 %, p = 0.01), tachypnoe above 30/min (37.9 % vs 13.7 %, p = 0.001) and acidosis with pH < 7.35 (27.6 % vs 8.9 %, p = 0.004) comparing to survived patients. No significant correlation between PSI and the length of hospitalisation in survived patients was observed. In patients with Staphylococcus sp. and Klebsiella pneumoniae infection, longer hospitalisation period was observed. Comparison of other parameters such as comorbidities, physical and laboratory findings, and pathogens showed no significant differences when comparing deceased to survived patients.

Conclusion:
Our study showed that PSI represents an important predictor of 30-day mortality in patients with CAP at ICU, but does not correlate neither with the length of hospitalisation nor with particular pathogens. Independent negative prognostic factors in CAP were age, incidence of heart diseases (most importantly ischaemic heart disease), tachycardia, tachypnoe and acidosis. Staphylococcus sp. and Klebsiella pneumoniae infection led to longer hospitalisation period. All these factors point out the need for increased care in CAP patients.

Keywords: pneumonia; pneumonia severity index; severity scoring system

Received: August 21, 2014; Accepted: October 20, 2014; Published: January 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hutyrová B, Jakubec P, Šindelářová Z, Šubová J, Langová K, Kolek V. Utility of Pneumonia Severity Index in hospitalized patients with pneumonia in intensive respiratory care units. Vnitr Lek. 2015;61(1):15-23.
Download citation

References

  1. Kolek V. Prognóza nemocných s komunitní pneumonií. Poučení z klinických doporučení, skórovacích systémů a dalších parametrů. Postgraduální medicína 2013; 15(8): 51-56.
  2. Kolek V, Kolář M, Kašák V et al. Diagnostika a léčba komunitní pneumonie dospělých. In: Kolek V et al. Doporučené postupy v pneumologii. Maxdorf: Praha 2013: 107-123. ISBN 978-80-7345-359-6.
  3. Beneš J, Džupová O, Blechová Z et al. Skórovací systémy hodnotící prognózu komunitních pneumonií. Vnitř Lék 2012; 58(5): 357-364. Go to PubMed...
  4. Jakubec P. Těžká komunitní pneumonie - uptodate 2013. Postgraduální medicína 2014; 16(2): 181-190.
  5. Jakubec P, Kolek V, Kolář M. Diagnostika a léčba těžké pneumonie. In: Kolek V et al. Doporučené postupy v pneumologii. Maxdorf: Praha 2013: 124-140. ISBN 978-80-7345-359-6.
  6. Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify lowrisk patients with community acquired pneumonia. N Engl J Med 1997; 336(4): 243-250. Go to original source... Go to PubMed...
  7. Chalmers JD, Rutherford J. Can we use severity assessment tools to increase outpatient management of community-acquired pneumonia? Eur J Int Med 2012; 23(5): 398-406. Go to original source... Go to PubMed...
  8. Renaud B, Coma E, Hayon J et al. PNEUMOCOM study investigators: Investigation of the ability of the Pneumonia Severity Index to accurately predict clinically relevant outcomes: a European study. Clin Microbiol Infect 2007; 13(9): 923-931. Go to original source... Go to PubMed...
  9. Angus DC, Marrie TJ, Obrosky DS et al. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med 2002; 166(5): 717-723. Go to original source... Go to PubMed...
  10. Choudhury G, Chalmers JD, Mandal P et al. Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients. Eur Respir J 2011; 38(3): 643-648. Go to original source... Go to PubMed...
  11. Bhadade RR, de Souza RA, Harde MJ et al. Clinical characteristics and outcomes of patients with acute lung injury and ARDS. J Postgrad Med 2011; 57(4): 286-290. Go to original source... Go to PubMed...
  12. Calle A, Márquez MA, Arellano M et al. Geriatric Assessment and Prognostic Factors of Mortality in Very Elderly Patients With Community-Acquired Pneumonia. Arch Bronconeumol 2014; 50(10):429-434. Go to original source...
  13. Planquette B, Le Pimpec-Barthes F, Trinquart L et al. Early respiratory acidosis is a new risk factor for pneumonia after lung resection. Interact Cardiovasc Thorac Surg 2012; 14(3): 244-248. Go to original source... Go to PubMed...
  14. Aliberti S, Amir A, Peyrani P et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest 2008; 134(5): 955-962. Go to original source... Go to PubMed...
  15. Sibila O, Meduri GU, Mortensen EM et al. Improving the 2007 Infectious Disease Society of America/American Thoracic Society severe community-acquired pneumonia criteria to predict intensive care unit admission. J Crit Care 2013; 28(3): 284-290. Go to original source... Go to PubMed...
  16. Corrales-Medina VF, Musher DM, Shachkina S et al. Acute pneumonia and the cardiovascular system. Lancet 2013; 381(9865): 496-505. Go to original source... Go to PubMed...
  17. Curley G, Contreras MM, Nichol AD et al. Hypercapnia and acidosis in sepsis: a double-edged sword? Anesthesiology 2010; 112(2): 462-472. Go to original source... Go to PubMed...
  18. Mor A, Thomsen RW, Ulrichsen SP et al. Chronic heart failure and risk of hospitalization with pneumonia: a population-based study. Eur J Intern Med 2013; 24(4): 349-353. Go to original source... Go to PubMed...
  19. Corrales-Medina VF, Musher DM, Wells GA et al. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 2012; 125(6): 773-781. Go to original source... Go to PubMed...
  20. Khand AU, Gemmell I, Rankin AC et al. Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges. Eur Heart J 2001; 22(2): 153-164. Go to original source... Go to PubMed...
  21. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010; 10(2): 83-92. Go to original source... Go to PubMed...
  22. Corrales-Medina VF, Suh KN, Rose G et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med 2011; 8(6): e1001048. Dostupné z DOI: <http://doi.org/10.1371/journal.pmed.1001048>. Go to original source... Go to PubMed...
  23. Corrales-Medina VF, Taljaard M, Fine MJ et al. Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia. Mayo Clin Proc 2014; 89(1): 60-68. Go to original source... Go to PubMed...
  24. Lippi G, Meschi T, Cervellin G. Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneumonia: clinical evidence and perspectives. Eur J Intern Med 2011; 22(5): 460-465. Go to original source... Go to PubMed...
  25. Chang CL, Mills GD, Karalus NC et al. Biomarkers of Cardiac Dysfunction and Mortality from Community-Acquired Pneumonia in Adults. PLoS One 2013; 8(5): e62612. Dostupné z WWW: <http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062612>. Go to original source... Go to PubMed...
  26. Cillóniz C, Ewig S, Polverino E et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax 2011; 66(4): 340-346. Go to original source... Go to PubMed...
  27. Lee YT, Chen SC, Chan KC et al. Impact of infectious etiology on the outcome of Taiwanese patients hospitalized with community acquired pneumonia. J Infect Dev Ctries 2013; 7(2): 116-124. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.